{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:48:07Z","timestamp":1789534087614,"version":"build-2803163510"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hyperuricemia is a metabolic disease caused by purine metabolism disorders. In recent years, its incidence has been increasing year by year and showing a trend of rejuvenation. It is closely associated with various health issues such as gout, kidney damage, and cardiovascular diseases. Therefore, standardizing and updating its treatment strategies holds significant clinical importance. This article systematically reviews the current various intervention methods and research status for the treatment of hyperuricemia: In the field of Western medicine, it deeply analyzes the efficacy, mechanism of action, and clinical limitations of drugs that promote uric acid excretion (such as benzbromarone and dotinurad), drugs that inhibit uric acid synthesis (such as allopurinol, febuxostat, and topiroxostat), and drugs that promote uric acid hydrolysis (such as pegloticase and rasburicase). It focuses on elaborating the research breakthroughs of URAT1 inhibitor derivatives and the new drug SHR4640. In the field of Traditional Chinese Medicine (TCM), from three aspects of single-herb monomers, compound prescriptions, and external treatment methods, it reveals their advantages in reducing uric acid through multiple mechanisms, including inhibiting xanthine oxidase (XOD), regulating uric acid transporters such as URAT1, GLUT9, and OATs, and improving intestinal homeostasis, with particular emphasis on the structure-activity relationship of flavonoids. At the same time, it details the action pathways and clinical evidence of emerging therapies such as SGLT2 inhibitors, the GLP-1\/GCG dual-receptor agonist Mazdutide, probiotics, and washed microbiota transplantation (WMT). By summarizing mechanistic insights, clinical progress, and translational prospects, this review aims to inform the development of individualized and integrative therapeutic strategies for hyperuricemia.<\/jats:p>","DOI":"10.3389\/fendo.2025.1722245","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:18:03Z","timestamp":1766121483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies"],"prefix":"10.3389","volume":"16","author":[{"given":"Xinze","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangman","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101717","DOI":"10.1016\/j.berh.2021.101717","article-title":"Urate transport in health and disease","volume":"35","author":"Kuhns","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.19538\/j.nk2023060106","article-title":"Multidisciplinary expert consensus on diagnosis and treatment of hyperuricemia-related diseases in China (2023 edition)","volume":"43","year":"2023","journal-title":"Chin J Pract Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01710","article-title":"Agents for the treatment of gout: current advances and future perspectives","volume":"66","author":"Zeng","year":"2023","journal-title":"J Med Chem"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7501\/j.issn.1674-6376.2021.08.037","article-title":"Research progress of drugs for treating gout and hyperuricemia","volume":"44","author":"Fu","year":"2021","journal-title":"Drug Eval Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.emcon.2025.100485","article-title":"Epidemiological perspectives on emerging contaminants and gout or hyperuricemia","author":"Fu","year":"2025","journal-title":"Emerg Contam"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202312_34797","article-title":"Comparison of the efficacy of febuxostat vs. benzbromarone in the treatment of gout: a meta-analysis in Chinese gout patients","volume":"27","author":"Yan","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0453","article-title":"Analysis of the efficacy and safety of benzbromarone combined with sodium bicarbonate tablets in the treatment of hyperuricemia","volume":"85","author":"Zhu","year":"2024","journal-title":"Br J Hosp Med (Lond)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2020.03.002","article-title":"Ideal pharmacokinetic profile of dotinurad as a selective urate reabsorption inhibitor","volume":"35","author":"Omura","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s10157-020-01849-0","article-title":"Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study","volume":"24","author":"Hosoya","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12882-024-03535-9","article-title":"Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease","volume":"25","author":"Amano","year":"2024","journal-title":"BMC Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107730","article-title":"URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease","volume":"26","author":"T Tanaka","year":"2023","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7501\/j.issn.1674-5515.2020.10.036","article-title":"Research progress of uric acid-lowering drugs affecting renal function in elderly patients with renal insufficiency","volume":"35","author":"Cai","year":"2020","journal-title":"Mod Drugs Clin"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.03.010","article-title":"Management of complex gout in clinical practice: Update on therapeutic approaches","volume":"32","author":"Narang","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2165911","article-title":"Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present)","volume":"32","author":"Shi","year":"2023","journal-title":"Expert Opin Ther Pat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152279","article-title":"Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies","volume":"63","author":"Qu","year":"2023","journal-title":"Semin Arthritis Rheumatol"},{"key":"B17","article-title":"New progress in research on drugs for treating hyperuricemia","volume":"30","author":"Zhou","year":"2021","journal-title":"Chin J New Drugs"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115532","article-title":"Identification of 5-[5-cyano-1-(pyridin-2-ylmethyl)-1H-indole-3-carboxamido] thiazole-4-carboxylic acid as a promising dual inhibitor of urate transporter 1 and xanthine oxidase","volume":"257","author":"Lin","year":"2023","journal-title":"Eur J Med Chem"},{"key":"B19","volume-title":"Establishment of two mouse models of hyperuricemia and their application in new drug discovery","author":"Qi","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: One enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092468","article-title":"Efficacy of xanthine oxidase inhibitors in lowering serum uric acid in chronic kidney disease: A systematic review and meta-analysis","volume":"11","author":"Lee","year":"2022","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000512178","article-title":"Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients","volume":"30","author":"Cicero","year":"2021","journal-title":"Med Princ Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5414\/CP203898","article-title":"Safety profiles of new xanthine oxidase inhibitors: A post-marketing study","volume":"59","author":"Wakabayashi","year":"2021","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101501","article-title":"Allopurinol hypersensitivity: Pathogenesis and prevention","volume":"34","author":"Stamp","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.40685","article-title":"Efficacy and safety of febuxostat extended and immediate release in patients with gout and renal impairment: A phase III placebo-controlled study","volume":"71","author":"Saag","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"New Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23643","article-title":"Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis","volume":"44","author":"Gao","year":"2021","journal-title":"Clin Cardiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.16438\/j.0513-4870.2021-1032","article-title":"Research progress of febuxostat derivatives as xanthine oxidase inhibitors","volume":"56","author":"Li","year":"2021","journal-title":"Acta Pharm Sin"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/life13112199","article-title":"Celebrating versatility: febuxostat's multifaceted therapeutic application","volume":"13","author":"Kraev","year":"2023","journal-title":"Life (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01198-x","article-title":"Febuxostat and renal outcomes: post-hoc analysis of a randomized trial","volume":"46","author":"Kohagura","year":"2023","journal-title":"Hypertens Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b22-00694","article-title":"Effect of topiroxostat on reducing oxidative stress in the aorta of streptozotocin-induced diabetic rats","volume":"46","author":"Noda","year":"2023","journal-title":"Biol Pharm Bull"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2021_88-518","article-title":"Effect of topiroxostat on brain natriuretic peptide level in patients with heart failure with preserved ejection fraction: A pilot study","volume":"88","author":"Wakita","year":"2021","journal-title":"J Nippon Med Sch"},{"key":"B33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40801-022-00291-w","article-title":"Evaluation of the effect of topiroxostat on renal function in patients with hyperuricemia: STOP-C study, a retrospective observational cohort study","volume":"9","author":"Tamiya","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"B34","doi-asserted-by":"publisher","first-page":"176915","DOI":"10.1016\/j.ejphar.2024.176915","article-title":"Topiroxostat improves glomerulosclerosis in type 2 diabetic Nagoya Shibata Yasuda mice with early nephropathy","volume":"982","author":"Hagiwara","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41387-021-00155-2","article-title":"Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice","volume":"11","author":"Nakamura","year":"2021","journal-title":"Nutr Diabetes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3969\/j.issn.2095-4174.2023.09.004","article-title":"Signal mining of adverse events of polyethylene glycol recombinant uricase injection based on FAERS database","volume":"12","author":"Gong","year":"2023","journal-title":"Rheumatism Arthritis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.semarthrit.2020.04.011","article-title":"Pegloticase treatment of chronic refractory gout: Update on efficacy and safety","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin Arthritis Rheumatol"},{"key":"B38","first-page":"114","article-title":"Research progress of drugs for treating hyperuricemia","volume":"19","author":"Zhang","year":"2024","journal-title":"China J Pharm Econ"},{"key":"B39","article-title":"Pathogenesis of hyperuricemia and research status of uric acid-lowering drug therapy","volume":"6","author":"Xia","year":"2022","journal-title":"Electron J Mod Med Health Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05364-6","article-title":"Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports","volume":"103","author":"Hammami","year":"2024","journal-title":"Ann Hematol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"107270","DOI":"10.1016\/j.mimet.2025.107270","article-title":"Microbial uricase enzymes in hyperuricemia management: Sources, challenges, and technological advances","author":"Pustake","year":"2025","journal-title":"J\u00a0Microbiol Methods"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.11842\/wst.20230829001","article-title":"Constitutional toxicology: a new direction for safety evaluation of Traditional Chinese Medicine","volume":"25","author":"Liu","year":"2023","journal-title":"World Sci Technol-Modernization Tradit Chin Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.14046\/j.cnki.zyytb2002.2015.01.025","article-title":"Study on the effects of active components in Gardenia jasminoides on XOD activity and mRNA expression in A549 cells","volume":"14","author":"Zhu","year":"2015","journal-title":"Tradit Chin Med Bull"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2018.1544981","article-title":"Isolation, characterization, and xanthine oxidase inhibitory activities of flavonoids from the leaves of Perilla frutescens","volume":"34","author":"Liu","year":"2020","journal-title":"Nat Prod Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-111012","article-title":"Salvia plebeia extract inhibits xanthine oxidase activity in vitro and reduces serum uric acid in an animal model of hyperuricemia","volume":"83","author":"Kim","year":"2017","journal-title":"Planta Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-1528.2017.03.035","article-title":"Effect of ethanol extract of Alisma orientale on hyperuricemia model rats induced by potassium oxonate","volume":"39","author":"Wang","year":"2017","journal-title":"Chin Tradit Pat Med"},{"key":"B47","article-title":"Inhibitory effect of Traditional Chinese Medicine monomers on xanthine oxidase","volume":"14","author":"Yu","year":"2023","journal-title":"Heilongjiang Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8728473","DOI":"10.1155\/2021\/8728473","article-title":"Total saponin of dioscorea collettii attenuates MSU crystal-induced inflammation by inhibiting the activation of the TLR4\/NF-\u03baB signaling pathway","author":"Guoying","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118182","article-title":"Traditional herbal medicine: therapeutic potential in acute gouty arthritis","volume":"330","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5246\/jcps.2025.08.055","article-title":"Mechanism of Smilax glabra-Rhizoma Coicis herb pair in treating gout and hyperuricemia based on network pharmacology and molecular docking (in English)","volume":"34","author":"Wang","year":"2025","journal-title":"J Chin Pharm Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"157079","DOI":"10.1016\/2025\/157079","article-title":"Combination of Withania coagulans and Fagonia cretica ameliorates hyperuricemia by re-modulating gut microbiota-derived spermidine and traumatic acid","author":"Naveed","year":"2025","journal-title":"Phytomedicine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115775","article-title":"Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2\/NLRP3 axis","volume":"301","author":"Ai","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134832","article-title":"A comprehensive review on recent xanthine oxidase inhibitors of dietary based bioactive substances for the treatment of hyperuricemia and gout: Molecular mechanisms and perspective","volume":"278","author":"Ullah","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7501\/j.issn.0253-2670.2018.06.020","article-title":"Study on anti-gout effect of hirudin and its mechanism","volume":"49","author":"Liu","year":"2018","journal-title":"Chin Tradit Herb Drugs"},{"key":"B55","volume-title":"Construction of quercetin-baicalein nano-delivery system and study on its urate-lowering activity","author":"Li","year":"2024"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.07.297","article-title":"Action mechanisms and interaction of two key xanthine oxidase inhibitors in galangal: combination of in vitro and in silico molecular docking studies","volume":"162","author":"Ou","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153585","article-title":"Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt\/\u03b2-catenin pathway","volume":"87","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1021\/jf505584m","article-title":"Novel insights into the inhibitory mechanism of kaempferol on xanthine oxidase","volume":"63","author":"Wang","year":"2015","journal-title":"J Agric Food Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.13863\/j.issn1001-4454.2024.08.035","article-title":"Urate-lowering effect of Dianthus chinensis and Polygonatum odoratum on hyperuricemic mice and their influence on renal urate transporter expression[J\/OL","author":"Shen","year":"2024","journal-title":"J Chin Med Mater"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118606","article-title":"9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice","volume":"335","author":"Wu","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.16438\/j.0513-4870.2021-1715","article-title":"Research progress of natural products with urate-lowering or anti-gout activity","volume":"57","author":"Zhang","year":"2022","journal-title":"Acta Pharm Sin"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1021\/np970237h","article-title":"Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers","volume":"61","author":"Cos","year":"1998","journal-title":"J Nat Prod"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01459-6","article-title":"Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment","volume":"46","author":"Guo","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.7501\/j.issn.0253-2670.2023.23.032","article-title":"Research progress of traditional Chinese medicine in the treatment of gout","volume":"54","author":"Liu","year":"2023","journal-title":"Chin Tradit Herb Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.13422\/j.cnki.syfjx.20201637","article-title":"Effect of Tongfengning on expression of renal urate transporters in hyperuricemic model rats","volume":"26","author":"Cai","year":"2020","journal-title":"Chin J Exp Tradit Med Formul"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120356","article-title":"Revealing disease-specific medication patterns of Wuling Powder: A large-scale data mining analysis of randomized controlled trials","volume":"353","author":"Lai","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.13702\/j.1000-0607.200708","article-title":"Study on the effect of electroacupuncture on serum uric acid and related indexes in patients with gouty arthritis","volume":"46","author":"Liu","year":"2021","journal-title":"Zhen Ci Yan Jiu"},{"key":"B68","article-title":"Mechanism study on the protective effect of \"Tongjing Lizhuo\" acupuncture on rats with acute gouty arthritis based on NF-\u03baB\/I\u03baB\u03b1 signaling pathway","volume":"31","author":"Qi","year":"2021","journal-title":"Chin J Comp Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28122","article-title":"Comparison of efficacy of acupuncture-related therapies in treating Acute Gouty Arthritis: A Network Meta-Analysis of Randomized Controlled Trials","volume":"10","author":"Fan","year":"2024","journal-title":"Heliyon"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115530","article-title":"Podophyllotoxin-induced acute kidney injury via the HMGB1\/TLR4\/MyD88\/NF-\u03baB axis in SD rats based on the toxicological evidence chain (TEC) concept via multiomic analysis","volume":"166","author":"Zhang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111360","article-title":"Metabolomics with gut microbiota analysis of podophyllotoxin-mediated cardiotoxicity in mice based on the toxicological evidence chain (TEC) concept","volume":"406","author":"Sun","year":"2025","journal-title":"Chemico-Biological Interact"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115392jia","article-title":"Nephrotoxicity assessment of podophyllotoxin-induced rats by regulating PI3K\/Akt\/mTOR-Nrf2\/HO1 pathway in view of toxicological evidence chain (TEC) concept","volume":"264","author":"Kong","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11480821","article-title":"SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and normal kidney function","volume":"17","author":"Suijk","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.10.030","article-title":"Hyperuricemia and gout reduction by SGLT2 inhibitors in diabetes and heart failure: JACC review topic of the week","volume":"83","author":"Packer","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.33007","article-title":"Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK\/AKT\/CREB signaling pathway in type 2 diabetic mice","volume":"16","author":"Lu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.08.020","article-title":"Uric acid and SGLT2 inhibition with empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-preserved trial","volume":"12","author":"Doehner","year":"2024","journal-title":"Heart Fail"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1038\/s41467-022-31328-x","article-title":"A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1038\/s41467-023-44067-4","article-title":"A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity","volume":"14","author":"Ji","year":"2023","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/db23-77-lb","article-title":"77-LB: A novel glucagon-like peptide-1 (GLP-1R) and glucagon (GCGR) receptor dual agonist, mazdutide (IBI362), attenuates hyperuricemia in hyperuricemic rats","volume":"72","author":"Jiang","year":"2023","journal-title":"Diabetes"},{"key":"B80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.12037\/YXQY.2024.07-04","article-title":"Preliminary study on urate-lowering effect of glucagon-like peptide\/glucagon dual receptor agonist Mazdutide on hyperuricemic rats based on transcriptomics","volume":"16","author":"Ren","year":"2024","journal-title":"Chin J Front Med Sci (Electron Ed)"},{"key":"B81","article-title":"Research progress of drugs for treating hyperuricemia","volume":"20","author":"Ma","year":"2025","journal-title":"China Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2021.1874287","article-title":"The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies","volume":"62","author":"Wang","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.935723","article-title":"Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.11.005","article-title":"Vitamins for the gut microbiome","volume":"26","author":"Steinert","year":"2020","journal-title":"Trends Mol Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms5010010","article-title":"Lactobacillus gasseri PA-3 uses the purines IMP, inosine and hypoxanthine and reduces their absorption in rats","volume":"5","author":"Yamada","year":"2017","journal-title":"Microorganisms"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jsfa.5797","article-title":"The probiotic Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 promote cholesterol efflux and suppress inflammation in THP-1 cells","volume":"93","author":"Yoon","year":"2013","journal-title":"J Sci Food Agric"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/VETSCI7030112","article-title":"Lactobacillus johnsonii L531 Ameliorates Escherichia coli-Induced Cell Damage via Inhibiting NLRP3 Inflammasome Activity and Promoting ATG5\/ATG16L1-Mediated Autophagy in Porcine Mammary Epithelial Cells","volume":"7","author":"Zou","year":"2020","journal-title":"Vet Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1159\/000521273","article-title":"Effects of washed microbiota transplantation on serum uric acid levels, symptoms, and intestinal barrier function in patients with acute and recurrent gout: A pilot study","volume":"40","author":"Xie","year":"2022","journal-title":"Dig Dis"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i11.3401","article-title":"Washed microbiota transplantation reduces serum uric acid levels in patients with hyperuricaemia","volume":"10","author":"Cai","year":"2022","journal-title":"World J Clin Cases"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.13995\/j.cnki.11-1802\/ts.039065","article-title":"Mechanism and progress of Ampelopsis grossedentata in anti-hyperuricemia[J\/OL","volume":"50","author":"Fan","year":"2024","journal-title":"Food Ferment Ind"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.13386\/j.issn1002-0306.2020080100","article-title":"Study on urate-lowering effect of Ampelopsis grossedentata extract","volume":"42","author":"Wu","year":"2021","journal-title":"Sci Technol Food Ind"},{"key":"B92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15905\/j.cnki.33-1157\/ts.2022.01.001","article-title":"Research progress on urate-lowering components of Pu'er tea and their mechanisms","author":"Yang","year":"2022","journal-title":"Food Ferment Ind"},{"key":"B93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.13305\/j.cnki.jts.2019.01.004","article-title":"Urate-lowering effect of black tea and its fungus-fermented red brick tea on hyperuricemic model mice","volume":"39","author":"Yuan","year":"2019","journal-title":"J Tea Sci"},{"key":"B94","first-page":"1","article-title":"Urate-lowering effect and mechanism of Anhua dark tea","volume":"45","author":"Gong","year":"2023","journal-title":"China Tea"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1722245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:18:19Z","timestamp":1766121499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1722245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":94,"alternative-id":["10.3389\/fendo.2025.1722245"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1722245","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"article-number":"1722245"}}